Nika BioTechnology, Inc Consolidated Financial Statement (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
USD ($)
| |
| Business Combination [Line Items] | |
| Accumulated Deficit | $ 9,004,009 |
| Nika Bio Technology [Member] | |
| Business Combination [Line Items] | |
| Cash | 322 |
| Inventory | 17,007 |
| Accruals | (3,833) |
| Due to related parties | (109,877) |
| Additional paid in capital | (5,388,284) |
| Accumulated Deficit | 5,464,629 |
| General and administrative expenses | $ 20,036 |
| X | ||||||||||
- Definition Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of accounts payable assumed in business combination and recognized at acquisition date, classified as current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liability assumed in business combination and recognized at acquisition date, classified as other and current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of inventory acquired in business combination and recognized at acquisition date, classified as current. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The expenses and losses recorded for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cumulative earnings (deficits) for relevant time periods. No definition available.
|
| X | ||||||||||
- Details
|